The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-(Cyclopentylamino)-9-methyl-9H-purin-8-yl)benzoic acid ID: ALA4167197
PubChem CID: 145954995
Max Phase: Preclinical
Molecular Formula: C18H19N5O2
Molecular Weight: 337.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(-c2ccc(C(=O)O)cc2)nc2c(NC3CCCC3)ncnc21
Standard InChI: InChI=1S/C18H19N5O2/c1-23-16(11-6-8-12(9-7-11)18(24)25)22-14-15(19-10-20-17(14)23)21-13-4-2-3-5-13/h6-10,13H,2-5H2,1H3,(H,24,25)(H,19,20,21)
Standard InChI Key: LZRUOHXWFCFBQE-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.7709 -11.3498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7697 -12.1694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4778 -12.5783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4760 -10.9410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1846 -11.3462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1849 -12.1694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9678 -12.4236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4515 -11.7574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9674 -11.0917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2655 -11.7557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6737 -12.4649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4902 -12.4650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8993 -11.7566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4861 -11.0467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6710 -11.0501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4735 -10.1238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2206 -13.2007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7646 -9.7173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6794 -8.9053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8795 -8.7377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4730 -9.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0217 -10.0523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7172 -11.7555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1270 -12.4625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1246 -11.0471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
4 16 1 0
7 17 1 0
16 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
23 24 1 0
23 25 2 0
13 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.38Molecular Weight (Monoisotopic): 337.1539AlogP: 3.08#Rotatable Bonds: 4Polar Surface Area: 92.93Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.83CX Basic pKa: 4.55CX LogP: 2.26CX LogD: -0.18Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -0.81
References 1. Lambertucci C, Marucci G, Dal Ben D, Buccioni M, Spinaci A, Kachler S, Klotz KN, Volpini R.. (2018) New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases., 151 [PMID:29614417 ] [10.1016/j.ejmech.2018.03.067 ]